Combined antihypertensive therapy in different types of obesity in postmenopausal women

Combined antihypertensive therapy in different types of obesity in postmenopausal women

The influence of combined antihypertensive therapy, including ACE inhibitor (ACEi) or Aliskiren, on the basic parameters of structural and functional state of the left ventricular (LV) myocardium in postmenopausal women with arterial hypertension (AH) and different types of obesity (abdominal and gl...

Full description

Bibliographic Details
Main Authors:	V. V. Skibitskiy, S. V. Skibitskaya, A. V. Fendrikova
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2013-12-01
Series:	Медицинский совет
Subjects:	женщины абдоминальное и глютео-феморальное ожирение артериальная гипертония постменопауза прямой ингибитор ренина ингибитор ангиотензинпревращающего фермента women, abdominal and gluteofemora obesity, hypertension, postmenopause, direct renin inhibitor women abdominal and gluteofemora obesity hypertension postmenopause direct renin inhibitor
Online Access:	https://www.med-sovet.pro/jour/article/view/1005

Similar Items

Aktivnost' renin-angiotenzinovoy sistemy (RAS) zhirovoy tkani: metabolicheskie effekty blokady RAS
Published: (2011-03-01)

COMPARISON OF EFFECTIVENESS OF COMBINATION ANTIHYPERTENSION THERAPY IN WOMEN WITH ABDOMINAL OR GLUTEO-FEMORAL OBESITY
by: V. V. Skibitsky, et al.
Published: (2016-10-01)

Dynamics of the main parameters of structure-functional condition of the left ventricle myocardium in usage of combination antihypertension therapy for postmenopausal women with different obesity patterns
by: V. V. Skibitsky, et al.
Published: (2016-04-01)

Kombinirovannaya terapiya ingibitorom angiotenzinprevrashchayushchego fermenta i diuretikom
by: I E Chazova, et al.
Published: (2006-06-01)

ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES
by: Z. M. Safiullina, et al.
Published: (2015-09-01)

ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION
by: N. A. Dzhaiani
Published: (2015-09-01)

In the wake of the latest clinical guidelines - mineralocorticoid receptor antagonists in the treatment of chronic heart failure
by: I. V. Zhirov, et al.
Published: (2015-12-01)

Gender differences renin-angiotensin-aldosterone system and its relation to humoral factors in patients with arterial hypertension
by: G M Dadashova
Published: (2015-09-01)

Effectiveness of combined antihypertensive treatment depending on the phenomenon of salt sensitivity in patients with refractory arterial hypertension
by: V V Skibitskiy, et al.
Published: (2015-12-01)

Primenenie ingibitorov angiotenzinprevrashchayushchego fermenta v lechenii arterial'noy gipertonii
by: A S Galyavich
Published: (2006-06-01)

Distribution of genotypes and alleles of the aldosterone-synthase gene in patients with abdominal obesity
by: D. L. Brovin, et al.
Published: (2015-06-01)

Apelin and heart remodeling in patients with abdominal obesity
by: O. V. Listopad, et al.
Published: (2015-06-01)

Renin as a target of direct pharmacological block in arterial hypertension
by: Nikolay Alekseevich Mukhin, et al.
Published: (2009-08-01)

SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW
by: S. R. Gilyarevskiy, et al.
Published: (2016-01-01)

Effektivnoe i bezopasnoe ispol'zovanie perindoprila v doze 8 mg v kachestve startovogo lecheniya bol'nykh arterial'noy gipertoniey v usloviyakh statsionara (po rezul'tatam issledovaniya DOMINANTA)
by: O D Ostroumova, et al.
Published: (2006-06-01)

Direct renin inhibitors aliskiren - possibilities correction cardiorenal syndrome
by: Irina Evgen'evna Chazova, et al.
Published: (2009-12-01)

Moexipril in arterial hypertension treatment among postmenopausal women with osteoporosis
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

Change of the level of adiponectin and metabolic indices in modification of life style of the patients suffering from abdominal obesity
by: A. V. Beresina, et al.
Published: (2015-03-01)

Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension
by: Karl Andersen
Published: (2009-03-01)

Sakharnyy diabet i arterial'naya gipertoniya: kakovy preparaty pervogo ryada vybora?
by: M V Shestakova
Published: (2005-03-01)

ALISKIREN (RENIN INHIBITOR) AS THE RECENT ANTIHYPERTENSIVE MODALITY
by: Luh Gde Primahatini Suaka Putri
Published: (2013-12-01)

Clinical efficacy of low-dose combination of bisoprolol and hydrochlorothiazide for the treatment of postmenopausal women with hypertension and thyroid pathology
by: R. I. Stryuk, et al.
Published: (2013-12-01)

Beneficial Effects of Breastfeeding on the Prevention of Metabolic Syndrome Among Postmenopausal Women
by: Jin Suk Ra, et al.
Published: (2020-08-01)

Arterial'naya gipertoniya i sakharnyy diabet: mekhanizmy razvitiya i taktika lecheniya
by: Marina Vladimirovna Shestakova
Published: (1999-09-01)

Клинико-экономическая оценка применения квинаприла
Published: (2018-06-01)

The Comparison of serum glutathione level between Hypertensive and Normotensive Postmenopausal Women
by: Mohammad Zarei, et al.
Published: (2017-11-01)

The results of the open observational, international, multicenter, prospective program to assess the efficacy, safety and tolerability of the first direct renin inhibitor RasilezR (aliskiren) in patients with arterial hypertension in ‘real-life’ clinical practice settings (DRIve)
by: I Ye Chazova
Published: (2014-09-01)

Aliskiren: An orally active renin inhibitor
by: Pranay Wal, et al.
Published: (2011-01-01)

The efficacy of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma exhibiting primary resistance to front-line targeted therapy or immunotherapy
by: L. Hamieh, et al.
Published: (2020-11-01)

Metabolic syndrome as a prothrombogenic state
Published: (2009-09-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Effect of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney disease
by: Li Szu-yuan, et al.
Published: (2012-08-01)

Musculoskeletal pain among postmenopausal women in Nigeria: Association with overall and central obesity
by: Omoyemi O. Ogwumike, PhD, et al.
Published: (2016-06-01)

HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
by: O. A. Kislyak, et al.
Published: (2017-07-01)

Vliyanie tsilazaprila na produktsiyu aktivnykh form kisloroda polimorfnoyadernymi leykotsitami u bol'nykh sakharnym diabetom 2 tipa
by: A V Sitozhevskiy, et al.
Published: (2000-12-01)

ASSESSMENT OF CLINICAL AND GENETIC RISK FACTORS OF ARTERIAL HYPERTENSION IN PERSONS YOUNGER THAN 35 YEARS OLD
by: I. M. Chernova, et al.
Published: (2015-04-01)

Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
by: Kalathil K Sureshkumar
Published: (2008-12-01)

Addition of Aliskiren to Angiotensin Receptor Blocker Improves Ambulatory Blood Pressure Profile and Cardiorenal Function Better than Addition of Benazepril in Chronic Kidney Disease
by: Satoshi Umemura, et al.
Published: (2013-07-01)

Torasemide: additional benefits for postmenopausal women with arterial hypertension
by: O N Tkacheva, et al.
Published: (2013-06-01)

Characteristics of postmenopausal women with acute coronary syndrome
by: Lourdes Elena Yera-Loyola, et al.
Published: (2021-03-01)

Cannot write session to /tmp/vufind_sessions/sess_r2ejn1e2038j5hvv4tcn28voi1